- Report
- September 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- August 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- June 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2025
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2025
- 282 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- January 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- September 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 274 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 197 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 898 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 380 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 172 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more